Description
LY2090314 is an inhibitor of glycogen synthase kinase (GSK-3).
Product Unit Size | Cost | Quantity | Stock |
---|
LY2090314 is an inhibitor of glycogen synthase kinase (GSK-3).
Cas No. | 603288-22-8 |
---|---|
Purity | ≥98% |
Formula | C28H25FN6O3 |
Formula Wt. | 512.53 |
IUPAC Name | 3-[6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]-4-imidazo[1,2-a]pyridin-3-ylpyrrole-2,5-dione |
Synonym | LY2090314 |
Solubility | DMSO 100 mg/mL (195.11 mM) Ethanol 2 mg/mL warmed (3.9 mM) Water Insoluble |
Appearance | Yellow Powder |
Store Temp | 4°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Zamek-Gliszczynski MJ, Abraham TL, Alberts JJ, et al. Pharmacokinetics, metabolism, and excretion of the glycogen synthase kinase-3 inhibitor LY2090314 in rats, dogs, and humans: a case study in rapid clearance by extensive metabolism with low circulating metabolite exposure. Drug Metab Dispos. 2013 Apr;41(4):714-26. PMID: 23305709.
Synthetic nitrile compound
Snake venom cardiotoxin found in Naja naja atra...
Diterpene found in brewed, unfiltered coffee; F...
MEK1 inhibitor.
Lipopeptide; 1,3-β-Glucan synthase inhibitor.<...
NSAID; COX-1/2 inhibitor.
Peptide, urocortin II analog; CRFR2 agonist.
Histamine H1 antagonist.
HDM2 inhibitor
Nitroimidazole, binds DNA; nucleic acid synthes...
Selective inhibitor of c-Met.
β2-adrenergic agonist.
Vitamin B, required for formation of NAD and NA...
PI3K and mTOR inhibitor.
Peptide, confers resistance against macrolide a...
p110α PI3K inhibitor.
Trihydroxybenzoic acid glycoside found in Berge...
Hec1/Nek2 mitotic pathway inhibitor
MEK1/2 and Raf inhibitor.
PDE3/5 inhibitor, LTD4 antagonist.